ACN vs CLBT: fair value comparison
Accenture plc and Cellebrite DI Ltd. · Updated 2026-10-19
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Technology, ACN currently sits closer to the top of our ranking by discount to fair value. CLBT carries the stronger quality grade.
| ACN | CLBT | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $209.06 | $11.03 |
| 12-month range | $124.44–$288.54 | $10.44–$19.28 |
| Rank by discount to fair value | #25 of 181 Technology | #26 of 181 Technology |
| Quality grade | B | A |
| Momentum grade | A | — |
| Leverage | Low | Low |
| Margin trend | Stable | Contracting |
| Revenue growth | Modest | Strong |
| RSI zone | Overbought | Neutral |
| 50/200-day trend | — | Downtrend |
| DCF cross-check | Fairly Valued | Overvalued |
| 52-week position | The upper-middle quarter | The bottom quarter |
Full single-stock breakdowns: ACN fair value analysis · CLBT fair value analysis